Azurity Pharmaceuticals India LLP

General

Total Cases1
Active Cases1
Patents--
TypeOperating Company
Elite Ratings
PTAB
--
--
--

Ratings

Experience
Grade
Trend
DCT
L2
E
PTAB
L5
A
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
02/03/25
REDACTED VERSION of [115] Answer to Counterclaim by Heron Therapeutics, Inc.. (Attachments: # [1] Exhibits 1-5)(Tigan, Jeremy) (Entered: 02/03/2025)
01/31/25
REDACTED VERSION of (114 in 1:24-cv-00830-WCB, 32 in 1:24-cv-01363-WCB) Unopposed MOTION to Redact (98 in 1:24-cv-00830-WCB) Transcript,, (16 in 1:24-cv-01363-WCB) Transcript,, by Azurity Pharmaceuticals, Inc., Slayback Pharma LLC, Azurity Pharmaceuticals India LLP. (Dorsney, Kenneth) (Entered: 01/31/2025)
01/27/25
Redaction of D.I. [98] Official Transcript of Oral Argument held on 12/30/24 before Judge William C. Bryson.. (mpb) (Entered: 01/27/2025)
01/27/25
ORAL ORDER: The Unopposed MOTION to Redact (98 in 1:24-cv-00830-WCB) Transcript,, (16 in 1:24-cv-01363-WCB) Transcript is GRANTED. The Clerk's Office shall file the redacted version of the transcript on the docket. Ordered by Judge William C. Bryson on 1/27/2025. Associated Cases: 1:24-cv-00830-WCB, 1:24-cv-01363-WCB(mpb) (Entered: 01/27/2025)
01/27/25
[SEALED] ANSWER to [105] Answer to Complaint, Counterclaim by Heron Therapeutics, Inc.. (Attachments: # [1] Exhibits 1-5)(Tigan, Jeremy) (Entered: 01/27/2025)
01/24/25
[SEALED] Unopposed MOTION to Redact (98 in 1:24-cv-00830-WCB) Transcript,, (16 in 1:24-cv-01363-WCB) Transcript,, - filed by Azurity Pharmaceuticals, Inc., Slayback Pharma LLC, Azurity Pharmaceuticals India LLP. (Dorsney, Kenneth) (Entered: 01/24/2025)
01/21/25
REDACTED VERSION of [105] Answer to Complaint, Counterclaim by Azurity Pharmaceuticals, Inc., Slayback Pharma LLC, Azurity Pharmaceuticals India LLP. (Dorsney, Kenneth) (Entered: 01/21/2025)
01/15/25
NOTICE OF SERVICE of Defendants Slayback Pharma LLC, Azurity Pharma India LLP, and Azurity Pharmaceuticals, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-91) filed by Slayback Pharma LLC, Azurity Pharmaceuticals India LLP.(Dorsney, Kenneth) (Entered: 01/15/2025)
01/15/25
SCHEDULING ORDER: Deadline for plaintiff's response to defendants' contentions due 02/10/2025; Parties identify opening claim terms and constructions 02/17/2025; Simultaneous opening claim construction briefs due 02/28/2025; Simultaneous responsive claim construction briefs due 03/14/2025; Deadline to meet and confer to narrow claim construction disputes 03/21/2025; Responsive expert reports due 06/13/2025; Reply expert reports due 06/27/2025; Deadline for expert discovery 07/25/2025; Opening summary judgment and Daubert briefs due 08/22/2025; Responsive summary judgment and Daubert briefs due 09/12/2025; Reply summary judgment and Daubert briefs due 09/19/2025; Pretrial conference TBD; Start of 4-day trial on 11/17/2025. Signed by Judge William C. Bryson on 01/15/2025. (Entered: 01/15/2025)
01/14/25
Letter to The Honorable William C. Bryson from Jeremy A. Tigan regarding Proposed Case Schedule. (Attachments: # [1] Exhibit A)(Tigan, Jeremy) (Entered: 01/14/2025)